We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

News   May 02, 2018 | Original story from Ecole Polytechnique Fédérale de Lausanne

 
Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

A model of a double-bridged peptide (the peptide in light blue, the two bridges in yellow). The background of the figures shows many examples of skeletons (also named "scaffolds" or "backbones") of double-bridged peptides. Credit: C. Heinis/EPFL

 
 
Advertisement
 

RELATED ARTICLES

Fungal Compound Inhibits BMP Receptors

News

Researchers in the group of Jeroen den Hertog, in collaboration with researchers in Leiden, have found that a compound inhibits a group of proteins called BMP receptors. This compound, called cercosporamide, was previously only known to inhibit a different group of proteins.

READ MORE

Compound Found in Blueberries Could Help To Treat Inflammatory Diseases

News

Various plants and their products are known to contain "bioactive" ingredients that can alleviate human diseases. These "phytocompounds" often contain restorative biological properties such as anti-cancerous, antioxidant, and anti-inflammatory effects. A team of researchers at Tokyo University of Science has been working this direction for the past several years, to identify novel active components in functional foods and understand their effects on the body.

READ MORE

Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection

News

A Phase III, randomized, double-blinded, placebo-controlled trial will help to determine if the dual-antibody treatment, REGN-COV2, can prevent infection in individuals who share a home with someone who has been diagnosed with COVID-19.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE